PrecisionPulse partners with executives, founders, and boards to bring structure to high-stakes innovation decisions. We turn uncertainty into clear governance, practical roadmaps, and defensible execution — across regulated product development, AI-enabled systems, and commercialization readiness.
PrecisionPulse is led by a global healthcare executive with 20 years of experience advancing complex programs across pharma, diagnostics, MedTech, and digital health.
Regulatory & Evidence Strategy
We define pathway and evidence strategy early to reduce rework and support submission-quality decisions across global markets.
AI Governance & Data Accountability
We establish governance operating models for AI-enabled products and enterprise systems — clarifying decision rights, controls, and lifecycle oversight aligned with evolving expectations.
Market Readiness & Lifecycle Strategy
We align quality, product, and commercialization planning so organizations can launch, operate, and scale with greater predictability across markets.
PrecisionPulse applies internally developed decision frameworks to support governance alignment and disciplined execution in regulated innovation environments. Frameworks are introduced and applied within engagements to clarify trade-offs, define accountability, and strengthen leadership decision-making.
PrecisionPulse works through defined, time-bound advisory engagements designed to bring clarity to critical decisions and establish structured next steps.
Regulatory Sprint (2 weeks)
Focused assessment of regulatory pathway, evidence strategy, and documentation posture with a prioritized action roadmap.
AI Governance QuickStart (30 days)
Design of governance operating model, accountability structure, and risk controls for AI-enabled systems.
Investor & Diligence Review (10 days)
Independent review of governance, quality, and regulatory readiness to inform capital decisions and transaction planning.
PrecisionPulse advises organizations operating in complex, regulated healthcare environments, including:
Venture-backed and growth-stage healthcare innovators
Developing diagnostics, devices, and AI-enabled platforms preparing for regulatory and market readiness.
Established healthcare and life sciences operators
Expanding across markets, strengthening governance structures, or scaling global operations.
Investors and boards
Seeking independent perspective on regulatory, governance, and operational readiness in high-stakes transactions.
Clients engage PrecisionPulse for independent, execution-oriented advisory grounded in senior leadership experience across regulated innovation. We are known for discretion, practical decision support, and disciplined delivery.